Molecular imaging pinpoints source of chronic back pain

June 6, 2011 in Other

A study introduced at SNM's 58th Annual Meeting shows potential relief for patients who suffer chronic pain after back surgery. A molecular imaging procedure that combines functional and anatomical information about the body is able to zero in on the site of abnormal bone reaction and provide more accurate diagnoses and appropriate pain management for patients who have received hardware implants or bone grafts.

"With PET/CT we can pinpoint the exact screw or rod that was loose or failing. We can help doctors and patients accurately decide whether surgical and nonsurgical treatment is the best option," says Andrew Quon, MD, assistant professor of radiology and chief of clinical PET/CT for the program at Stanford University, Stanford, Calif. "This eliminates unnecessary or erroneous hardware replacement surgeries and provides a surgical map for patients who need further operations to treat their chronic ."

Serious spinal instability and disease often necessitate the implantation of hardware such as plates, cages, rods and screws or to support the spine. There are many reasons why patients experience pain after initial surgery, including hardware failure and infection, or both. Determining the source of pain can be difficult, especially when patients have complex medical histories. In this study, a combination of positron and computed tomography (PET/CT) and F18 NaF, an injected radiotracer that uses sodium fluoride to target "hot spots" or areas of high bone turnover and inflammation during imaging, was used to evaluate patients with back pain after spinal surgery. This form of molecular imaging was shown to be highly accurate in determining the culprit of patient's chronic pain by highlighting both the structure of the bone and the physiological processes involved in inflammation, an indication of injury and infection.

For this prospective study, 20 patients presenting with spinal pain were evaluated with PET/CT using F18 NaF at least eight months after surgery. A total of 24 bone or tissue abnormalities were found in 17 of the 20 subjects. Of the original 20 patients, 12 received exploratory surgery and four participants received local anesthetic nerve blockade, a common and minimally invasive treatment that numbs the affected nerve, providing short-term pain management as an alternative to surgery. The research indicates that F18 NaF PET/CT is highly effective for the evaluation of pain after spinal —in more than 85 percent of cases, this form of molecular imaging was able to identify the exact source of patient's pain.

More information: Scientific Paper 457: A. Quon, C. Sprinz, M. Rodrigues de Abreu, J. Maria Alves Neto, A. Iagaru, S. Hennermann, Stanford University, Stanford, CA; Hospital Mãe de Deus, Porto Alegre, Brazil; "Integrated F18 NaF PET/CT scanning for the evaluation of patients with chronic pain after spinal surgery," SNM's 58th Annual Meeting, June 4-8, 2011, San Antonio, TX.

Provided by Society of Nuclear Medicine search and more info website

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Researcher calls for new approach to regulating probiotics

In today's Nature scientific journal Dr. Gregor Reid, Director of the Canadian R&D Centre for Probiotics at Lawson Health Research Institute and a scientist at Western University, calls for a Category Tree system to be imp ...

Other created 9 hours ago | popularity not rated yet | comments 1 | with audio podcast

Professor conducting study to determine whether supplements help muscles grow

Nutritional supplements are often associated with athletes and body builders, but a University of Kansas professor is conducting a research project to determine whether they are in fact, effective and if they might be able ...

Other created 14 hours ago | popularity not rated yet | comments 0

Researchers develop IT solution to help disabled make better wheelchair selections

A Wayne State University researcher has introduced computer technology that makes it easier for people who need wheelchairs to select one that best suits their needs.

Other created May 23, 2012 | popularity not rated yet | comments 0

Study shows how patients use Facebook to solicit kidney donations

Loyola University Medical Center researchers are reporting one of the first studies to examine how patients and families are soliciting living kidney donors on Facebook.

Other created May 23, 2012 | popularity not rated yet | comments 0

WHO's Chan re-elected for second term

The World Health Organisation on Wednesday re-appointed Margaret Chan as its chief, who declared universal health care as her top priority.

Other created May 23, 2012 | popularity not rated yet | comments 0


Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments

A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...